Increased risk of cognitive impairment in patients with diabetes is associated with metformin
- PMID: 24009301
- PMCID: PMC3781568
- DOI: 10.2337/dc13-0229
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
Erratum in
- Diabetes Care. 2013 Nov;36(11):3850
Abstract
Objective: To investigate the associations of metformin, serum vitamin B12, calcium supplements, and cognitive impairment in patients with diabetes.
Research design and methods: Participants were recruited from the Primary Research in Memory (PRIME) clinics study, the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging, and the Barwon region of southeastern Australia. Patients with Alzheimer disease (AD) (n=480) or mild cognitive impairment (n=187) and those who were cognitively intact (n=687) were included; patients with stroke or with neurodegenerative diseases other than AD were excluded. Subgroup analyses were performed for participants who had either type 2 diabetes (n=104) or impaired glucose tolerance (n=22).
Results: Participants with diabetes (n=126) had worse cognitive performance than participants who did not have diabetes (n=1,228; adjusted odds ratio 1.51 [95% CI 1.03-2.21]). Among participants with diabetes, worse cognitive performance was associated with metformin use (2.23 [1.05-4.75]). After adjusting for age, sex, level of education, history of depression, serum vitamin B12, and metformin use, participants with diabetes who were taking calcium supplements had better cognitive performance (0.41 [0.19-0.92]).
Conclusions: Metformin use was associated with impaired cognitive performance. Vitamin B12 and calcium supplements may alleviate metformin-induced vitamin B12 deficiency and were associated with better cognitive outcomes. Prospective trials are warranted to assess the beneficial effects of vitamin B12 and calcium use on cognition in older people with diabetes who are taking metformin.
Figures
Comment in
-
Comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.Diabetes Care. 2014 Jun;37(6):e150. doi: 10.2337/dc13-2473. Diabetes Care. 2014. PMID: 24855178 Free PMC article. No abstract available.
-
Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.Diabetes Care. 2014 Jun;37(6):e151. doi: 10.2337/dc14-0278. Diabetes Care. 2014. PMID: 24855179 No abstract available.
References
-
- González EL, Johansson S, Wallander MA, Rodríguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009;63:332–336 - PubMed
-
- Monesi L, Baviera M, Marzona I, Avanzini F, Monesi G, Nobili A, et al. Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study. Diabet Med 2012;29:385–392 - PubMed
-
- Maga A, de Courten M, Dan L, et al. American Samoa NCD Risk Factors STEPS Report. Suva, Fiji, Department of Health, World Health Organization, 2007
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
